Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines
US11197890B2 · kind B2 · utility
1Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 12, 2017 |
| Grant date | Dec 14, 2021 |
| Priority date | — |
| Expiry date | Aug 28, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The current invention is related to the prevention and treatment of diseases including cancer, autoimmune disease, and infectious disease using CXC chemokines and the receptors to which they agonize. It has been found that certain chemokines, including CXCL4, CXCL9, CXCL10, and CXCL12 have various effects on toll-like receptors in various cell types and these can be utilized for disease treatment and prevention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.